Genetic testing done for a 55-year-old woman diagnosed with an unusually mild case of AADC deficiency revealed a disease-causing…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Treatment with sertraline, an antidepressant sold under the brand name Zoloft among others, worked to ease anxiety in a young…
The first successes of gene therapy for AADC deficiency highlight the potential that gene therapies have to improve life…
Following gene therapy, people with AADC deficiency should receive a few weeks of intensive physical therapy, with additional physical…
Researchers say childhood epilepsy and mild attention deficits were effectively “hiding” a case of mild aromatic l-amino acid decarboxylase…
Most people with rare diseases given an experimental therapy through compassionate use programs show clinical benefits, and most of these…
Although AADC deficiency is characterized by low levels of signaling molecules in the brain that impair its normal function,…
PTC Therapeutics will meet with the U.S. Food and Drug Administration (FDA) in December to review the data the company…
The AADC enzyme can undergo a process called phosphorylation at a specific molecular site to increase its activity, a study…
A new artificial intelligence (AI) tool — OpenAI’s GPT application programming interface (API) — has been integrated into FindZebra,…